Publications of F. Holsboer
All genres
Journal Article (878)
1997
Journal Article
770, pp. 184 - 191 (1997)
Soluble tumor necrosis factor (p75) does not attenuate the sleep changes induced by lipopolysaccharide in the rat during the dark period. Brain Research
Journal Article
27, pp. 355 - 362 (1997)
Premorbid psychometric profile of subjects at high risk for affective disorders. Psychological Medicine
Journal Article
16, pp. 51 - 60 (1997)
Sleep in schizophrenia; a polysomnographic study on drug-naive patients. Neuropsychopharmacology
Journal Article
17, pp. 4448 - 4460 (1997)
Long-term intracerebroventricular infusion of corticotropin-releasing hormone alters neuroendocrine, neurochemical, autonomic, behavioral and cytokine responses to a systemic inflammatory challenge. Journal of Neuroscience
Journal Article
65, pp. 216 - 222 (1997)
Corticosteroid receptor function is decreased in depressed patients. Neuroendocrinology
Journal Article
8 (1997)
Intact spatial learning and memory in transgenic mice with reduced BDNF. Neuroreport
Journal Article
58, pp. 329 - 336 (1997)
Central administration of IL-1 reduces anxiety and induces sickness behaviour in rats. Pharmacology Biochemistry & Behavior
Journal Article
762, pp. 12 - 18 (1997)
Behavioural performance in three substrains of mouse strain 129. Brain Research
Journal Article
99, pp. 962 - 966 (1997)
Neonatal treatment of rats with the neuroactive steroid tetrahydrocorticosterone (THDOC) abolishes the behavioral and neuroendocrine consequences of adverse early life events. Journal of Clinical Investigation
Journal Article
54, pp. 89 - 90 (1997)
Smoking affects plasma soluble IL-2 receptor levels in patients with schizophrenia. Archives of General Psychiatry
Journal Article
11, pp. 641 - 648 (1997)
Schlaf und Immunsystem. Schlafmodulation durch Zytokine. T & E Neurologie Psychiatrie
Journal Article
175, p. 1284 - 1284 (1997)
Circadian time structure of septic shock - timing is everything - reply. Journal of Infectious Diseases
Journal Article
65, pp. 189 - 199 (1997)
Increased stress-induced adrenocorticotropin response after long-term intracerebroventricular treatment of rats with antisense mineralocorticoid receptor oligodeoxynucleotides. Neuroendocrinology
Journal Article
9, pp. 201 - 205 (1997)
Changes in sleep-endocrine activity after growth hormone-releasing hormone depend on time of administration. Journal of Neuroendocrinology
Journal Article
331, pp. 97 - 107 (1997)
Centrally administered oligodeoxynucleotides in rats: Occurence of non-specific effects. European Journal of Pharmacology
Journal Article
9, pp. 210 - 221 (1997)
Infusions of tyrosine hydroxylase antisense oligodesoxynucleotides into the substantia nigra in vivo: effects on THmRNA, TH protein content, striatal dopamine release and behavior. European Journal of Neuroscience
Journal Article
72, pp. 81 - 88 (1997)
Nocturnal secretion of prolactin and cortisol and the sleep EEG in patients with major endogenous depression during an acute episode and after full remission. Psychiatry Research
Journal Article
20, pp. 1038 - 1052 (1997)
Neuropeptides and human sleep. Sleep
Journal Article
65, pp. 210 - 215 (1997)
Central and peripheral administration of atriopeptin is anxiolytic in rats. Neuroendocrinology
Journal Article
42, pp. 882 - 888 (1997)
The effect of repeated human corticotropin-releasing hormone administration on dexamethasone-suppressed pituitary-adrenocortical activity in healthy subjects. Biological Psychiatry